Industry Insights

  1. Mock Inspection Advice From Former Regulatory Investigator 12/30/2025

    Former FDA investigator Alia Legaux, D.H.Sc., runs through her top tips for running a mock investigation.

  2. FDA Further Expands And Clarifies Expanded Access FAQs 12/29/2025

    Healthcare attorney Dianne J. Bourque breaks down the FDA's October 2025 update to its Expanded Access FAQs.

  3. The Rise Of Antimicrobial Resistance And Strategic Research Imperatives For 2026 12/26/2025

    Antimicrobial resistance (AMR) has increasingly worried public health officials and researchers alike in 2025. Now, in 2026, TAXI Pharmaceutical President and CEO Gregory G. Mario, MBA, is calling for more targeted approaches and the integration of AI for quicker discovery and development.

  4. Clinical Trials Are The Global Biopharma Industry's Biggest Headache 12/23/2025

    Explore how technology-driven, patient-centered innovation is transforming clinical trials to reduce risk, improve efficiency, and deliver smarter development outcomes.

  5. Virtual eConsent For Decentralized Trials 12/23/2025

    Virtual eConsent improves accessibility and compliance in decentralized trials, streamlining enrollment with a secure, user-friendly process for informed consent in remote research.

  6. Streamlining Trials With eConsent And EDC 12/23/2025

    Integrating eConsent with EDC streamlines clinical workflows, improves data accuracy, and enhances patient engagement by creating a unified, compliant system for consent and trial data management.

  7. Preparing Clinical Teams for 2026: AI, Automation & Integration 12/23/2025

    Clinical teams should prepare for 2026 by embracing AI, automation, and unified platforms to improve efficiency, data quality, and scalability in increasingly complex trials.

  8. Clinical Data Modernization: A 2026 Starter Guide 12/23/2025

    Clinical data modernization replaces outdated systems with integrated cloud solutions, improving data quality, accelerating insights, and streamlining workflows for more efficient trials.

  9. At-Home Clinical Trials: When At-Home Ophthalmic Exams Make Sense 12/23/2025

    At-home ophthalmic exams in clinical trials improve patient accessibility, reduce site burden, and maintain data integrity, enabling decentralized research without sacrificing quality or compliance.

  10. Hybrid Ophthalmic Trials: Splitting Visits Across Home, Hub, And Site 12/23/2025

    Hybrid ophthalmic trials combine in-person and remote visits, boosting patient convenience, reducing site burden, and accelerating timelines while maintaining data quality and compliance.